Product export scorecard · GTİP 3004.60.00.00.00Medicaments containing any of the following antimalarial active principles: artemisinin…Official Turkish text: Anti-sıtma aktif maddelerini (Faslın 2 no.lu alt pozisyon notu) içeren ilaçlar; dozlandırılmış veya perakende satış için ambalajlanmış
Its biggest market for the heading is Georgia: €156m in the 12 months to August 2026 (+7.4% on the year before). In Saudi Arabia, Türkiye's share is 0.3%: US$11.4m in the 12 months to April 2026.
From official statistics and the tenders on Birlesa, each with its source and date; refreshed as new tenders arrive.
News for this product
New tenders and purchase requests, Türkiye's new duties, duties and recalls abroad, new requirements and buying signals: by e-mail, with a free account.
Source: Eurostat, Comext DS-059341. Growth rates and shares are calculated by Birlesa from Eurostat's figures; Eurostat bears no responsibility for them.
Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones, alkaloids, provitamins, vitamins, or their derivatives)
Official Turkish title: Anti-sıtma aktif maddelerini (Faslın 2 no.lu alt pozisyon notu) içeren ilaçlar; dozlandırılmış veya perakende satış için ambalajlanmış
Its place in the tariff
Chapter 30Pharmaceutical products
Heading 3004Medicaments; (not goods of heading no. 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic use, put up in measured doses (incl. those in the form of transdermal admin. systems) or packed for retail sale
Subheading 3004.60Medicaments; containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale
CN code 3004.60.00Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones, alkaloids, provitamins, vitamins, or their derivatives)
2As Türkiye reports (no figures of the market's own)
From Türkiye, 12 months
€68.5m-14.1%
Market's imports
Not published
In EU member markets, industrial goods enter duty-free with an A.TR movement certificate under Decision 1/95 of the EC-Turkey Association Council (the Customs Union); coal and steel products under the 1996 ECSC agreement, with a EUR.1. Agricultural products' rate is TARIC's. Trade-defence measures such as anti-dumping duties apply on top.
Ranked by Türkiye's own exports over 12 months, as Türkiye reports them, in one currency for every market; then by their growth. Each row shows the market's own figures where it publishes them. 127 markets have figures for this heading.
Source: Eurostat, Comext DS-059341. Growth rates and shares are calculated by Birlesa from Eurostat's figures; Eurostat bears no responsibility for them.
50% of eligible expenses, up to 75% under the conditions below
On the stand's area in square metres, at most 5 fairs a year (10 for the participants and makers the circular qualifies). 70% in the Ministry's target countries, 75% in its target countries and sectors.
